Pluristem Therapeutics (PSTI) Scientists To Present A Poster On Gvhd & Participate In A Panel Discussion At The BIRAX Regenerative Medicine Conference
3/25/2014 9:33:12 AM
HAIFA, Israel, March 25, 2014 (GLOBE NEWSWIRE) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR), a leading developer of placenta-based cell therapies, today announced its participation in the 2nd UK-Israel Regenerative Medicine Conference (BIRAX), which is being held on March 25th and 26th, 2014 in Haifa at the Ruth and Bruce Rappaport Faculty of Medicine, Technion - Israel Institute of Technology.
Help employers find you! Check out all the jobs and post your resume.
comments powered by